VAERS Explorer
Back to explore

Report #2891241

Received Mar 31, 2026

ER / ED visit
A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
Mar 17, 2026
Onset
Mar 18, 2026
Days to onset
1
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RVXROTAVIRUS (NO BRAND NAME)UNKNOWN MANUFACTURERUNKUNK—

Symptoms (1)

Injection site mass

Symptom narrative

Large lump under skin at injection site; This non-serious case was reported by a consumer and described the occurrence of injection site lump in a 66-year-old female patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On 17-MAR-2026, the patient received RSV vaccine. On 18-MAR-2026, 1 days after receiving RSV vaccine, the patient experienced injection site lump (Verbatim: Large lump under skin at injection site). The outcome of the injection site lump was not resolved. It was unknown if the reporter considered the injection site lump to be related to RSV vaccine. It was unknown if the company considered the injection site lump to be related to RSV vaccine. Additional Information: GSK Receipt Date: 19-MAR-2026 The batch number was not provided and unable to contact the reporter.